Javascript must be enabled to continue!
Williams Controls (a)
View through CrossRef
Williams Controls CEO, John Easton, has outlined the new strategic plan he wants to put in place to improve the company's market opportunities and accelerate its growth. The plan involves embarking on an expansive acquisition spree designed to vertically integrate the company's supply chain and simultaneously expand its product offering beyond the core electronic throttle control (ETC) business. Easton's plan sounded compelling but complicated and introduced new risks to a small company that was beginning to find its operating groove. If successful, Easton's plan could revolutionize Williams Controls and take it to heights once thought unreachable, but if unsuccessful, it could derail the company.
Excerpt
UVA-S-0190
Jul. 11, 2011
WILLIAMS CONTROLS (A)
Williams Controls' board of directors sat at their board meeting, staring at each other. They had just heard a lengthy and impassioned pitch from the company's CEO, John Easton, outlining the new strategic plan he wanted to put in place to improve the company's market opportunities and accelerate its growth. The plan involved embarking on an expansive acquisition spree designed to vertically integrate the company's supply chain and simultaneously expand its product offering beyond the core electronic throttle control (ETC) business. The board knew its duty was to help the CEO steer the growth and evolution of the company over time while also ensuring that the interests of its shareholders were protected. Easton's plan sounded compelling but complicated and introduced new risks to a small company that was beginning to find its operating groove. If successful, Easton's plan could revolutionize Williams Controls and take it to heights once thought unreachable, but if unsuccessful, it could derail the company. As Gene Goodrich, one of board's senior directors, rose from the table to break for dinner, he looked at his fellow board members and said, “Well, folks, John has given us much to think about tonight.”
The Early Years
In the 1930s, Norman C. Williams, a young engineer and entrepreneur in Portland, Oregon, noticed that the logging trucks pervasive throughout the region were suffering from brake overheating as they hauled timber from the mountains of the Pacific Northwest down to the nearby ports. Truck accidents were frequent, and expensive brake replacements were routine. To address the problem, Williams invented a vacuum water valve designed to cool the brake drums of the trucks as they barreled down the mountainside roads. His invention worked and became an instant hit with local logging companies. In 1937, Williams Controls opened for business in Portland and began marketing Williams's new brake valves to trucking companies throughout the region.
. . .
Title: Williams Controls (a)
Description:
Williams Controls CEO, John Easton, has outlined the new strategic plan he wants to put in place to improve the company's market opportunities and accelerate its growth.
The plan involves embarking on an expansive acquisition spree designed to vertically integrate the company's supply chain and simultaneously expand its product offering beyond the core electronic throttle control (ETC) business.
Easton's plan sounded compelling but complicated and introduced new risks to a small company that was beginning to find its operating groove.
If successful, Easton's plan could revolutionize Williams Controls and take it to heights once thought unreachable, but if unsuccessful, it could derail the company.
Excerpt
UVA-S-0190
Jul.
11, 2011
WILLIAMS CONTROLS (A)
Williams Controls' board of directors sat at their board meeting, staring at each other.
They had just heard a lengthy and impassioned pitch from the company's CEO, John Easton, outlining the new strategic plan he wanted to put in place to improve the company's market opportunities and accelerate its growth.
The plan involved embarking on an expansive acquisition spree designed to vertically integrate the company's supply chain and simultaneously expand its product offering beyond the core electronic throttle control (ETC) business.
The board knew its duty was to help the CEO steer the growth and evolution of the company over time while also ensuring that the interests of its shareholders were protected.
Easton's plan sounded compelling but complicated and introduced new risks to a small company that was beginning to find its operating groove.
If successful, Easton's plan could revolutionize Williams Controls and take it to heights once thought unreachable, but if unsuccessful, it could derail the company.
As Gene Goodrich, one of board's senior directors, rose from the table to break for dinner, he looked at his fellow board members and said, “Well, folks, John has given us much to think about tonight.
”
The Early Years
In the 1930s, Norman C.
Williams, a young engineer and entrepreneur in Portland, Oregon, noticed that the logging trucks pervasive throughout the region were suffering from brake overheating as they hauled timber from the mountains of the Pacific Northwest down to the nearby ports.
Truck accidents were frequent, and expensive brake replacements were routine.
To address the problem, Williams invented a vacuum water valve designed to cool the brake drums of the trucks as they barreled down the mountainside roads.
His invention worked and became an instant hit with local logging companies.
In 1937, Williams Controls opened for business in Portland and began marketing Williams's new brake valves to trucking companies throughout the region.
.
.
.
Related Results
Welcome to the Robbiedome
Welcome to the Robbiedome
One of the greatest joys in watching Foxtel is to see all the crazy people who run talk shows. Judgement, ridicule and generalisations slip from their tongues like overcooked lamb ...
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abstract
Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This ra...
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
Abstract
Background
Postoperative acute kidney injury (AKI) is a common complication of major gastrointestinal surgery with an i...
Intravenous Vitamin C for Patients Hospitalized With COVID-19
Intravenous Vitamin C for Patients Hospitalized With COVID-19
ImportanceThe efficacy of vitamin C for hospitalized patients with COVID-19 is uncertain.ObjectiveTo determine whether vitamin C improves outcomes for patients with COVID-19.Design...
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
IMPORTANCE
Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19.
...
John Williams
John Williams
John Williams (b. 1932) is one of the most successful composers to have worked in cinema. His background includes classical education in piano and composition and extensive experie...
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Importance
The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown.
...

